Literature DB >> 31918563

Surgical margins for borderline and malignant phyllodes tumours.

A Thind1, B Patel2, K Thind3, J Isherwood4, B Phillips5, K Dhaliwal6, D D Remoundos7.   

Abstract

BACKGROUND: Phyllodes tumours represent less than 1% of all UK breast neoplasms. Histological features allow classification into benign, borderline or malignant, which has a significant impact on prognosis and recurrence. Currently, there is no consensus for the optimal surgical excision margin. This systematic review aims to provide a comparative summary of outcomes (local recurrence, metastasis and survival) for borderline and malignant phyllodes tumours resected with either ≥1cm or <1cm margins.
METHODS: MEDLINE and Embase were systematically searched (1990 to July 2019), in line with PRISMA guidelines. Study quality was assessed using the Newcastle-Ottawa scale.
RESULTS: Ten retrospective studies were included (Newcastle-Ottawa scale mean score: 5.6, range: 8-4). Nine reported local recurrence rates, four reported distant metastasis and four reported survival. Meta-analysis pooling demonstrated no statistically significant difference between <1cm and ≥1cm margins in terms of local recurrence rates (relative risk [RR] 1.43, 95% confidence interval [95% CI] 0.70 - 2.93; p=0.33, n=456), distant metastasis (RR 1.93, 95% CI 0.35 - 10.63; p=0.45, n=72) or mortality (RR 1.93, 95% CI 0.42 - 8.77; p=0.40, n=58) for borderline and malignant tumours. Additionally, two studies demonstrated no significant difference in local recurrence for borderline tumours excised with <0.1cm margins compared to ≥1cm.
CONCLUSION: Current evidence suggests that margins <1cm may provide adequate tumour excision. This could enable breast conservation in patients with smaller breast-to-tumour volume ratios, with improved cosmetic outcomes and patient satisfaction. A prospective, multi-institutional trial would be appropriate to further elucidate the safety of smaller margins.

Entities:  

Keywords:  Borderline; Clearance; Malignant; Margin; Phyllodes tumour; Recurrence; Surgery; Survival

Mesh:

Year:  2020        PMID: 31918563      PMCID: PMC7027423          DOI: 10.1308/rcsann.2019.0140

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  26 in total

1.  The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan.

Authors:  Chin-Chan Lin; Hui-Wen Chang; Chen-Yuan Lin; Chang-Fang Chiu; Shin-Pen Yeh
Journal:  Int J Clin Oncol       Date:  2012-07-07       Impact factor: 3.402

2.  A retrospective review of phyllodes tumours of the breast: A single institution experience.

Authors:  Vithusha Ganesh; Leah Drost; Justin Lee; Bo Angela Wan; Liying Zhang; Eileen Rakovitch; Danny Vesprini; Elzbieta Slodkowska; K Liang Zeng; Philomena Sousa; Caitlin Yee; Henry Lam; Edward Chow
Journal:  Breast       Date:  2017-12-09       Impact factor: 4.380

3.  Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study.

Authors:  Kaveh Borhani-Khomani; Maj-Lis Møller Talman; Niels Kroman; Tove Filtenborg Tvedskov
Journal:  Ann Surg Oncol       Date:  2015-12-29       Impact factor: 5.344

4.  Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.

Authors:  M F Rodrigues; P T Truong; E C McKevitt; L M Weir; M A Knowling; E S Wai
Journal:  Cancer Radiother       Date:  2018-03-07       Impact factor: 1.018

Review 5.  Phyllodes tumours.

Authors:  S J Parker; S A Harries
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

6.  Adjuvant radiotherapy for phyllodes tumor of breast.

Authors:  A W Chaney; A Pollack; M D McNeese; G K Zagars
Journal:  Radiat Oncol Investig       Date:  1998

7.  Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.

Authors:  Edwin O Onkendi; Rafael E Jimenez; Grant M Spears; William S Harmsen; Karla V Ballman; Tina J Hieken
Journal:  Ann Surg Oncol       Date:  2014-07-18       Impact factor: 5.344

8.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01

9.  Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast.

Authors:  J W Mituś; P Blecharz; T Walasek; M Reinfuss; J Jakubowicz; J Kulpa
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

10.  Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.

Authors:  Samer Sawalhi; Marwa Al-Shatti
Journal:  Ann Saudi Med       Date:  2013 Mar-Apr       Impact factor: 1.526

View more
  4 in total

1.  Surgical management in phyllodes tumors of the breast: a systematic review and meta-analysis.

Authors:  Yufan Wei; Yanying Yu; Yashuang Ji; Yuting Zhong; Ningning Min; Huayu Hu; Qingyu Guan; Xiru Li
Journal:  Gland Surg       Date:  2022-03

2.  Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence.

Authors:  Yang Li; Yixuan Song; Ronggang Lang; Lu Shi; Shuang Gao; Hong Liu; Ping Wang
Journal:  Breast       Date:  2021-03-17       Impact factor: 4.380

Review 3.  Phyllodes Tumors: A Scoping Review of the Literature.

Authors:  Jessica Bogach; Saad Shakeel; Frances C Wright; Nicole J Look Hong
Journal:  Ann Surg Oncol       Date:  2021-07-22       Impact factor: 5.344

Review 4.  A giant malignant phyllodes tumor of breast post mastectomy with metastasis to stomach manifesting as anemia: a case report and review of literature.

Authors:  Hui-Pu Liu; Wen-Yen Chang; Chin-Wen Hsu; Shan-Tao Chien; Zheng-Yi Huang; Wen-Ching Kung; Ping-Hung Liu
Journal:  BMC Surg       Date:  2020-08-15       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.